Prostate Artery Embolization (PAE) is a minimally invasive treatment for men suffering from an enlarged prostate, a condition known as benign prostatic hyperplasia (BPH).
By reducing arterial supply, PAE aims to shrink prostate tissue and improve lower urinary-tract symptoms. It has different risks from surgery, not no surgical risks; symptom relief can be incomplete or delayed and retreatment may be needed.
About this scan
Common Indications for PAE
Your doctor may request a PAE if you experience:
- A frequent or urgent need to urinate, especially during the night.
- A weak urine stream or difficulty starting urination.
- The feeling that your bladder is never completely empty.
- You want an alternative to surgery (like a TURP procedure) to avoid sexual side effects like erectile dysfunction or retrograde ejaculation.
Will it be painful?
The procedure is virtually painless. You are given relaxing IV medicine and the entry site is completely numbed. After the procedure, you might feel a mild, dull ache in your pelvis or experience frequent urination for a few days as the prostate reacts to the treatment, but severe pain is very rare.
Before your appointment
Do I need to prepare?
Yes. You will be asked to fast before the procedure. You may also need a blood test to check your kidney function and an ultrasound or MRI to evaluate the size of your prostate.
During the scan
What happens during the procedure?
A tiny tube is inserted into an artery in your groin or wrist. Using a specialized X-ray dye, the doctor maps out the tiny arteries feeding the prostate gland. Microscopic particles are then injected through the tube to block these blood vessels. Over the following weeks, the lack of blood flow causes the enlarged prostate to safely shrink.
How long does it take?
The procedure usually takes 1 to 2 hours. It is performed as an outpatient treatment, meaning you can typically go home the same day.
Safety and special situations
What are the important limitations and safety checks?
Interventional radiology is minimally invasive, but it is not risk-free and is not automatically safer or more effective than surgery, endoscopy, medicines, or observation for every patient. Technical success does not always produce symptom relief or cure disease, and repeat treatment or another approach may be needed. Suitability depends on anatomy, disease severity, comorbidities, imaging, local expertise, and the alternatives available.
Risks vary by procedure and may include pain, bleeding, infection, contrast reaction, kidney injury, radiation exposure, vessel or organ injury, clotting, device movement or blockage, sedation complications, treatment failure, and an unplanned operation or admission. Tissue sampling can be nondiagnostic and requires pathology; tumor treatments require oncology follow-up. The consent discussion should cover the patient-specific benefits, material risks, alternatives, and what happens if the procedure cannot be completed.
Preparation is individualized. Give the team a complete list of anticoagulants, antiplatelet drugs, diabetes medicines, supplements, allergies, kidney problems, pregnancy possibility, and prior contrast reactions. Do not stop a blood thinner or diabetes medicine on your own: the procedural team and prescribing clinician must balance bleeding against thrombosis or metabolic risk and provide exact written instructions. Fasting, laboratory tests, antibiotics, sedation, escort, admission, and aftercare differ by procedure.
Sources and summary
Sources and further reading
Conclusion
PAE is an option for selected benign prostatic enlargement after urologic assessment. Outcomes and sexual side-effect profiles vary by comparator and patient. Urinary retention, infection, nontarget embolization, access complications, treatment failure, and later surgery remain possible, and prostate cancer or another cause of symptoms must not be overlooked.